Correlation Between Delcath Systems and Neuropace

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Delcath Systems and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Delcath Systems and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Delcath Systems and Neuropace, you can compare the effects of market volatilities on Delcath Systems and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Delcath Systems with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Delcath Systems and Neuropace.

Diversification Opportunities for Delcath Systems and Neuropace

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between Delcath and Neuropace is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Delcath Systems and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Delcath Systems is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Delcath Systems are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Delcath Systems i.e., Delcath Systems and Neuropace go up and down completely randomly.

Pair Corralation between Delcath Systems and Neuropace

Given the investment horizon of 90 days Delcath Systems is expected to generate 18.0 times less return on investment than Neuropace. But when comparing it to its historical volatility, Delcath Systems is 1.58 times less risky than Neuropace. It trades about 0.01 of its potential returns per unit of risk. Neuropace is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  771.00  in Neuropace on August 28, 2024 and sell it today you would earn a total of  295.00  from holding Neuropace or generate 38.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Delcath Systems  vs.  Neuropace

 Performance 
       Timeline  
Delcath Systems 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Delcath Systems has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Delcath Systems is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders.
Neuropace 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Delcath Systems and Neuropace Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Delcath Systems and Neuropace

The main advantage of trading using opposite Delcath Systems and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Delcath Systems position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.
The idea behind Delcath Systems and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume